Canixa Competitors and Similar CompaniesClear all

Evofem Biosciences's competitors and similar companies include Revance Therapeutics.
Evofem Biosciences
Evofem Biosciences
Evofem Biosciences, a clinical-stage biopharmaceutical company, develops and commercializes women’s sexual and reproductive health products.
Revance Therapeutics
Revance Therapeutics
Revance Therapeutics is a biotechnology company that develops and commercializes aesthetic and therapeutic offerings.
Founding Date
Founding Date
2007
Founding Date
2002
Type
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
Nashville, US HQ
Irvine, US
Newark, US
Pleasanton, US
Employees
Employees
3030% increase
Employees
59712% increase
Valuation ($)
Valuation ($)
1.2 m
Valuation ($)
615.7 m

Financial

Revenue (est.)
Revenue (est.)
$20.2m (FY, 2025)
Revenue (est.)
$234m (FY, 2023)
Cost of goods
Cost of goods
$4.6m (FY, 2025)
Cost of goods
$74.4m (FY, 2023)
Gross profit
Gross profit
$15.6m (FY, 2025)
Gross profit
$159.7m (FY, 2023)
Net income
Net income
$391k (FY, 2025)
Net income
($324m) (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

Revance Therapeutics
HQ
Nashville, US
Employees
597↑ 12% increase

Revance Therapeutics is a biotechnology company that develops and commercializes aesthetic and therapeutic offerings.

View company